Table 2.
Variable | OR (95% CI) | p value |
---|---|---|
Total cohort (N= 135) | ||
GFAP | 1.009 (1.004–1.015) | <0.001 |
MELD | 1.038 (0.945–1.140) | 0.433 |
Male sex | 1.482 (0.642–3.422) | 0.357 |
Albumin | 0.933 (0.877–0.992) | 0.028 |
History of OHE | 4.662 (1.297–16.755) | 0.018 |
Only patients without a history of OHE (n = 118) | ||
GFAP | 1.009 (1.004–1.014) | <0.001 |
MELD | 1.035 (0.939–1.140) | 0.489 |
Male sex | 1.385 (0.573–3.346) | 0.470 |
Albumin | 0.934 (0.876–0.995) | 0.035 |
p values < 0.05 are highlighted in bold font. CHE, covert hepatic encephalopathy; GFAP, glial fibrillary acidic protein; MELD, model for end-stage liver disease; OHE, overt hepatic encephalopathy; OR, odds ratio.